dc.creator | Santos-Sánchez, Guillermo | es |
dc.creator | Cruz-Chamorro, Ivan | es |
dc.creator | Álvarez-Ríos, Ana Isabel | es |
dc.creator | Lardone, Patricia Judith | es |
dc.creator | Guerrero Montávez, Juan Miguel | es |
dc.creator | Bejarano Hernando, Ignacio | es |
dc.creator | Carrillo Vico, Antonio | es |
dc.date.accessioned | 2021-09-21T16:40:55Z | |
dc.date.available | 2021-09-21T16:40:55Z | |
dc.date.issued | 2021-07-29 | |
dc.identifier.citation | Santos-Sánchez, G., Cruz-Chamorro, I., Álvarez-Ríos, A.I., Lardone, P.J., Guerrero, J.M., Bejarano, I. y Carrillo Vico, A. (2021). Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice. Antioxidants, 10 (8), art.n.1222. | |
dc.identifier.issn | 2076-3921 (electrónico) | es |
dc.identifier.uri | https://hdl.handle.net/11441/126090 | |
dc.description.abstract | Metabolic-associated fatty liver disease (MAFLD) is the most important cause of liver
disease worldwide. It is characterized by the accumulation of fat in the liver and is closely associated
with abdominal obesity. In addition, oxidative stress and inflammation are significant features
involved in MAFLD. Recently, our group demonstrated that lupin protein hydrolysates (LPHs) had
lipid lowering, antioxidant, and anti-inflammatory effects. Sixty male mice fed with a Western diet
were intragastrically treated with LPHs (or vehicle) for 12 weeks. Liver and adipose tissue lipid
accumulation and hepatic inflammatory and oxidant status were evaluated. A significant decrease in
steatosis was observed in LPHs-treated mice, which presented a decreased gene expression of CD36
and LDL-R, crucial markers in MAFLD. In addition, LPHs increased the hepatic total antioxidant
capacity and reduced the hepatic inflammatory status. Moreover, LPHs-treated mice showed a
significant reduction in abdominal adiposity. This is the first study to show that the supplementation
with LPHs markedly ameliorates the generation of the steatotic liver caused by the intake of a Western
diet and reduces abdominal obesity in ApoE−/− mice. Future clinical trials should shed light on the
effects of LPHs on MAFLD. | es |
dc.description.sponsorship | Ministerio de Economía y Competitividad [AGL2012-40247-C02-01 and AGL2012-40247-C02-02] | es |
dc.description.sponsorship | Andalusian Government Ministry of Health [PC-0111-2016-0111] | es |
dc.description.sponsorship | PAIDI Program from the Andalusian Government [CTS160] | es |
dc.description.sponsorship | Spanish Ministerio de Educación, Cultura y Deporte [FPU16/02339] and [FPU13/01210] | es |
dc.description.sponsorship | The National Net RETICEF for Aging Studies (RD12/0043/0012 from the Instituto de Salud Carlos III, Spanish Ministerio de Ciencia e Innovación) | es |
dc.description.sponsorship | European Social Fund and Spanish Ministerio de Empleo y Seguridad Social [EJ-086] | es |
dc.description.sponsorship | Andalusian Government Ministry of Health [PI-0136-2019] | es |
dc.description.sponsorship | VI Program of Inner Initiative for Research and Transfer of University of Seville (VI PPIT-US) | es |
dc.format | application/pdf | es |
dc.format.extent | 15 p. | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.ispartof | Antioxidants, 10 (8), art.n.1222. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Lupin | es |
dc.subject | Bioactive peptides | es |
dc.subject | NAFLD | es |
dc.subject | Oxidative stress | es |
dc.subject | Inflammation | es |
dc.subject | Adipose tissue | es |
dc.subject | Steatosis | es |
dc.subject | Cholesterol | es |
dc.subject | LDL | es |
dc.title | Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología | es |
dc.relation.projectID | AGL2012-40247-C02-01 | es |
dc.relation.projectID | AGL2012-40247-C02-02 | es |
dc.relation.projectID | PC-0111-2016-0111 | es |
dc.relation.projectID | CTS160 | es |
dc.relation.projectID | FPU16/02339 | es |
dc.relation.projectID | FPU13/01210 | es |
dc.relation.projectID | RD12/0043/0012 | es |
dc.relation.projectID | EJ-086 | es |
dc.relation.projectID | PI-0136-2019 | es |
dc.relation.projectID | VI PPIT-US | es |
dc.relation.publisherversion | https://www.mdpi.com/2076-3921/10/8/1222 | es |
dc.identifier.doi | 10.3390/antiox10081222 | es |
dc.journaltitle | Antioxidants | es |
dc.publication.volumen | 10 | es |
dc.publication.issue | 8 | es |
dc.publication.initialPage | art.n.1222 | es |